T201-0037 Screening compound: 2-(3,4-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

T201-0037 Screening compound: 2-(3,4-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide
T201-0037 Screening compound: 2-(3,4-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T201-0037
2-(3,4-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T201-0037

Molecular Formula

C23H26N4O3S (C23 H26 N4 O3 S)

Compound Name

2-(3,4-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

IUPAC name

2-(34-dimethoxyphenyl)-N-[3-(methylsulfanyl)phenyl]-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-5-carboxamide

SMILES

COc(ccc(-c1nn(CCCN(C2)C(Nc3cccc(SC)c3)=O)c2c1)c1)c1OC

InChI

InChI=1S/C23H26N4O3S/c1-29-21-9-8-16(12-22(21)30-2)20-14-18-15-26(10-5-11-27(18)25-20)23(28)24-17-6-4-7-19(13-17)31-3/h4,6-9,12-14H,5,10-11,15H2,1-3H3,(H,24,28)

InChI Key

YHTIIQYNDICKKN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27618655

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.591

Distribution Coefficient, logD

3.591

Water Solubility, LogSw

-3.81

Polar Surface Area

54.499

Acid Dissociation Constant (pKa)

14.05

Base Dissociation Constant (pKb)

0.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

T201-0037 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with T201-0037 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T201-0037?
Check Price and Availability of T201-0037, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T201-0037 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T201-0037
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T201-0037
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T201-0037 available by request